Skip to main content
. 2004 Nov 1;114(9):1227–1232. doi: 10.1172/JCI23396

Figure 3.

Figure 3

Immune evasion by tumors or infectious agents could take place by excess Treg renewal, resulting in suppression of specific effector T cells. Anti-Treg vaccination could restore health by inducing Treg loss, leading to effector T cell renewal and rejection of the tumor or infectious agent.